3 Magnificent Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 8.5% -- to Buy With Confidence in November

New research indicates dividend stocks have significantly outperformed non-dividend stocks, delivering a 9.2% annualized return compared to 4.31% for non-payers from 1973-2024. Building on this, the article identifies three ultra-high-yield dividend stocks as compelling buys for November: Sirius XM Holdings (5% yield), which benefits from a subscription-driven monopoly and trades at a 45% discount to its average forward P/E; Pfizer (7% yield), despite recent COVID-19 therapy sales declines, has achieved over 50% sales growth since 2020, bolstered by the Seagen acquisition, and trades at a 22% P/E discount; and PennantPark Floating Rate Capital (13.5% yield), a debt-focused BDC with variable-rate loans benefiting from current interest rate dynamics, trading at a 17% discount to book value.

Analysis

Research by Hartford Funds and Ned Davis Research indicates dividend stocks significantly outperformed non-dividend stocks from 1973-2024, yielding 9.2% annualized versus 4.31%. This historical outperformance highlights the strategic importance of income-generating equities for long-term portfolio growth.

Sirius XM Holdings (SIRI) is presented as an ultra-high-yield opportunity with a 5% yield, underpinned by its legal monopoly in satellite radio and a robust subscription-based revenue model (76% of net revenue). The company's predictable cash flow and current valuation at a 7x forward P/E, representing a 45% discount to its five-year average, make it attractive.

Pfizer (PFE), yielding 7%, has achieved over 50% sales growth since 2020, despite a post-pandemic decline in COVID-19 therapy sales from $56 billion to $11 billion. The $43 billion Seagen acquisition in December 2023 is set to bolster its oncology pipeline and drive cost synergies, while the stock trades at a 7.8x forward P/E, a 22% discount to its five-year average.

PennantPark Floating Rate Capital (PFLT), a BDC, offers a 13.5% yield, primarily through variable-rate debt investments in middle-market businesses. Its weighted average yield on debt investments reached 10.4% due to rising interest rates, and 99% of its $2.16 billion loan portfolio is variable-rate. PFLT is currently trading at a 17% discount to its book value, signaling a potential entry point.

Key Decisions for Investors

• Consider increasing exposure to high-quality dividend stocks, supported by their historical outperformance of 9.2% annualized returns compared to non-payers' 4.31%.
• Evaluate Sirius XM Holdings (SIRI) for its predictable subscription revenue, legal monopoly, and 45% discount to its average forward P/E.
• Assess Pfizer (PFE) for its underlying sales growth post-COVID therapy peak, strategic oncology expansion via Seagen, and 22% P/E discount.
• Review PennantPark Floating Rate Capital (PFLT) for its 13.5% variable-rate yield, debt-focused BDC model, and 17% discount to book value.